Table 2.
Subjects’ physiological and anthropometric characteristics in three stages (Baseline, 12 weeks, 16 weeks) and two groups (Exercise and Control)
| Parameters | Group | Baseline | 12 weeks | 16 weeks | Observed power | |||
|---|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean | SD | |||
| Age (year) | Ex | 8.42 | 0.75 | 8.67 | 0.83 | 8.9 | 0.85 | – |
| Con | 8.28 | 0.64 | 8.53 | 0.66 | 8.61 | 0.71 | – | |
| Height (cm) | Ex | 134.5 | 9.2 | 134.9 | 6.71 | 135 | 5.36 | 0.89 |
| Con | 134.2 | 8.31 | 134.5 | 9.56 | 135.1 | 7.88 | 0.89 | |
| Weight (kg) | Ex | 40.51 | 1.98 | 38.25a c | 2.51 | 38.94a b c | 2.33 | 1 |
| Con | 39.93 | 1.97 | 40.05 | 1.9 | 40.09 | 1.91 | 0.87 | |
| BMI (kg/m2) | Ex | 21.76 | 1.53 | 20.47a c | 1.56 | 20.78 a b c | 1.61 | 1 |
| Con | 21.75 | 1.71 | 21.76 | 1.72 | 21.76 | 1.72 | 0.55 | |
| BMI SDS | Ex | 1.71 | 0.14 | 1.18 a c | 0.1 | 1.43 a b c | 0.13 | 0.97 |
| Con | 1.72 | 0.23 | 1.75 | 0.24 | 1.77 | 0.18 | 0.94 | |
| FMI (kg/m2) | Ex | 9.54 | 2.49 | 8.67 | 2.21a c | 8.86 a b c | 2.25 | 1 |
| Con | 9.42 | 2.33 | 9.49 | 2.44 | 9.53 | 2.47 | 0.88 | |
| BF (%) | Ex | 36.57 | 9.7 | 34.20 | 8.5 a c | 34.79 a b c | 8.56 | 1 |
| Con | 36.29 | 9.59 | 36.89 | 9.68 | 36.92 | 9.69 | 0.89 | |
| TC (mg/dl) | Ex | 195.8 | 5.23 | 168.1a c | 4.71 | 171.58 a b c | 5.39 | 1 |
| Con | 196.3 | 6.34 | 193 | 6.41 | 193.8 | 7.38 | 0.88 | |
| LDL (mg/dl) | Ex | 124 | 5.71 | 98.57a c | 3.5 | 100 a b c | 4.25 | 0.93 |
| Con | 124.7 | 6.01 | 123.4 | 5.55 | 123.03 | 6.1 | 0.91 | |
| HDL (mg/dl) | Ex | 39 | 2.21 | 48.5a c | 2.1 | 47.29 a b c | 3.51 | 0.85 |
| Con | 39 | 2.54 | 40.2 | 3.59 | 40.55 | 3.92 | 0.77 | |
| TG (mg/dl) | Ex | 83.5 | 3.33 | 72a c | 4.2 | 77.33 a b c | 5.07 | 1 |
| Con | 84 | 4.58 | 84.6 | 5.78 | 85.11 | 6.23 | 1 | |
| SBP (mmHg) | Ex | 114.5 | 7.28 | 102.19a c | 5.9 | 107 b c | 9.14 | 1 |
| Con | 114.8 | 10.59 | 112.5 | 10.28 | 116.2 | 10.73 | 0.58 | |
| DBP (mmHg) | Ex | 71.7 | 0.93 | 69.5 | 0.91 | 70.66 | 1.01 | 0.64 |
| Con | 75.9 | 1.27 | 74 | 1.9 | 75 | 1.25 | 0.68 | |
| RHR | Ex | 84.35 | 8.79 | 82.28 | 8.49 | 83.27 | 7.93 | 0.94 |
| Con | 85.96 | 7.22 | 84.39 | 7.57 | 84.2 | 6.71 | 0.92 | |
| 6MWT (m) | Ex | 570 | 43 | 696a c | 49 | 605b | 48.58 | 1 |
| Con | 581 | 45 | 599 | 48.1 | 575 | 47.99 | 0.84 | |
| Vo2peak (ml/kg/min) | Ex | 37.7 | 4.36 | 40.21a c | 5.11 | 38.68b | 6.27 | 1 |
| Con | 37 | 5.99 | 38.06 | 6.01 | 38.05 | 6.81 | 0.93 | |
Data presented include the mean and standard deviation (SD). a: significantly different from baseline, b: significantly different from 12 weeks, c: significantly different from the control group. P<0.05 (Ex: Exercise group n = 15, Con: Control group n = 15, BMI: Body Mass Index, SDS: Standard Deviation Score, FMI: Fat Mass Index, BF: Body Fat, TC: Total Cholesterol, LDL: Low-Density Lipoprotein, HDL: High-Density Lipoprotein, TG: Triglycerides, SBP: Systolic Blood Pressure, DBP: Diastolic Blood Pressure, RHR: Resting Heart Rate, 6MWT: 6-Minute Walk Test,Vo2 peak: Peak oxygen uptake)